Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Salih Sertac Durusoy"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S32- (2022)
Objective: Mantle cell lymphoma (MCL) is an agressive B-cell lymphoma, constitutes 3-10% of all non-Hodgkin's lymphomas. MCL usually presents with generalized lymph node involvement. The prognosis is poor and incurable. Extranodal involvement is not
Externí odkaz:
https://doaj.org/article/5a4ffbbf744741f990f0637d343998be
Autor:
Ilknur Demir, Vahap Okan, Salih Sertac Durusoy, M. Pehlivan, Handan Haydaroglu Sahin, Sacide Pehlivan, Yasemin Oyaci, Istemi Serin
Publikováno v:
BMC Research Notes, Vol 14, Iss 1, Pp 1-6 (2021)
BMC Research Notes
BMC Research Notes
Objective Studies on the genetic background of patients with multiple myeloma (MM) have been increasing; two important factors considered in such works are uncoupling protein-2 (UCP-2) and nuclear receptor subfamily 3 group C member 1 (NR3C1). We aim
Autor:
Filiz Türe Özdemir, Osman Ozdogan, Cigdem Ataizi-Celikel, Erdem Kombak, Ender Gunes Yegin, Salih Sertac Durusoy
Publikováno v:
Annals of Hepatology, Vol 18, Iss 6, Pp 833-840 (2019)
Introduction and objectives: A crucial issue when appraising the performance of non-invasive markers is the limitations of the reference standard they are compared to. Digital image analysis (DIA) was suggested as a reproducible approach expressing f
Autor:
Mustafa Pehlivan, Ilknur Gundes, Salih Sertac Durusoy, Melya Pelin Kirik, Aliye Serpil Sarifakiogullari, Handan Haydaroglu Sahin
Publikováno v:
European Journal of Therapeutics. 24:262-265
Autor:
Ilknur Demir, Mustafa Pehlivan, Idris Ince, Tahir Alper Cinli, Istemi Serin, Ahmet Kursad Gunes, Serpil Sarifakiogullari, Dervis Murad Akkurt, Gulkan Ozkan, Salih Sertac Durusoy
Publikováno v:
Hematology/Oncology and Stem Cell Therapy.
Objective/Background: Lymphoma is seen as a highly treatable and curable malignancy with aggressive treatment methods. Efficacy is often limited by toxicity and many patients need alternative treatment strategies as they cannot tolerate existing high
Autor:
Sehmus Ertop, Alperen Kizikli, Rahsan Yildirim, Huseyin Derya Dincyurek, Nilgun Sayinalp, Sinan Demircioğlu, Güray Saydam, Ismet Aydogdu, Abdulkadir Basturk, Erdal Kurtoğlu, Ahmet Seyhanli, Olga Meltem Akay, Hatice Terzi, Burak Deveci, Omer Ozcan, Eren Arslan Davulcu, Güven Çetin, Ali Ünal, Emel Gürkan, Vahap Okan, Elif Gülsüm Ümit, Aydan Akdeniz, Burhan Turgut, Vildan Özkocamaz, Anil Tombak, Derya Selim Batur, Mehmet Sönmez, Ilhami Berber, Burhan Ferhanoglu, Birsen Sahip, Mehmet Ali Ucar, Ahmet Kursad Gunes, Mehmet Yilmaz, Mehmet Ali Özcan, Mehmet Hilmi Dogu, Gül İlhan, Gülsüm Özet, Seval Akpinar, Funda Pepedil Tanrikulu, Demet Çekdemir, Emin Kaya, Özgür Mehtap, Mufide Okay, Irfan Yavasoglu, Salih Sertac Durusoy
Publikováno v:
Turkish Journal of Hematology
Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients (mean age +/- standard devia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5976c7adba53564e1d4f94514645acfd
https://hdl.handle.net/20.500.11776/8832
https://hdl.handle.net/20.500.11776/8832
Autor:
Mehmet Yilmaz, Salih Sertac Durusoy, Alperen Kizikli, Mahmut Yeral, Ilknur Kozanoglu, Salih Subari, Azer Abiyev, Sibel Cangi
Publikováno v:
Journal of Leukemia.
In this report we present three patients who are 70, 50 and 55 years of ages with complaints of fatigue, pallor, weakness and epistaxis. The Peripheral Blood (PB) smear and bone marrow aspiration (BMA) showed circulating blast cells, lymphocytes, and
Autor:
Salih Sertac Durusoy, Anil Tombak, Alperen Kizikli, Mehmet Sönmez, Mehmet Ali Özcan, Erdal Kurtoğlu, Mehmet Hilmi Dogu, Ahmet Seyhanli, Ali Ünal, Emel Gürkan, Rahsan Yildirim, Vahap Okan, Nilgun Sayinalp, Seval Akpinar, Burhan Turgut, Sehmus Ertop, Güray Saydam, Mehmet Ali Ucar, Burak Deveci, Güven Çetin, Gül İlhan, Omer Ozcan, Eren Arslan Davulcu, Özgür Mehtap, Mehmet Yilmaz, Ilhami Berber, Elif Gülsüm Ümit, Abdulkadir Basturk, Burhan Ferhanoglu, Birsen Sahip, Sinan Demircioğlu, Emin Kaya, Ismet Aydogdu, Mufide Okay, Irfan Yavasoglu, Meltem Olga Akay, Derya Selim Batur, Ahmet Kursat Gunes, Hatice Terzi, Aydan Akdeniz, Vildan Ozkocaman, Gülsüm Özet, Funda Pepedil Tanrikulu
Publikováno v:
Blood. 134:5476-5476
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 07-10, 2019 -- Orlando, FL
BERBER, Ilhami/0000-0003-3312-8476
WOS:000577164606194
[No Abstract Available]
Amer Soc Hematol
BERBER, Ilhami/0000-0003-3312-8476
WOS:000577164606194
[No Abstract Available]
Amer Soc Hematol
PB1977 LATE DIAGNOSIS IN SYRIAN IMMIGRANT PATIENT; THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME
Publikováno v:
HemaSphere. 3:897
Autor:
Özgür Mehtap, Tayfur Toptas, Mehmet Sinan Dal, Güner Hayri Özsan, Nigün Sayinalp, Güray Saydam, Mehmet Ali Uçar, Hakki Onur Kirgizlar, Ozan Salim, Atakan Tekinalp, Fahir Özkalemkaş, Funda Pepedil Tanrikulu, Olga Meltem Akay, Emrah Kiliçaslan, Semra Paydas, Sinem Civriz, Mehmet Yilmaz, Volkan Karakuş, Fatma Geçgel, Tahir Darçin, Elçin Erdoğan, Erkin Çinar, Fatma Keklik Karadağ, Ünal Ataş, Vildan Gürsoy, Salih Sertaç Durusoy, Elif Birtaş Ateşoğlu, Anil Tombak, Nurhilal Büyükkurt, Muhit Özcan, Fevzi Altuntaş, Ahmet Burhan Ferhanoğlu
Publikováno v:
HemaSphere, Vol 7, p e566791c (2023)
Externí odkaz:
https://doaj.org/article/e9b3c75689fe4673b443fbabb3a75f21